Bogol, Baby Girl -.
HRN: 23-34-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2023
07/24/2023
IV
44mg
Q24
PSNB
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes